期刊： HEART AND VESSELS, 2022; 37 (7)
Left bundle branch area pacing (LBBAP) has developed in an effort to improve cardiac resynchronization therapy (CRT). We aimed to compare the long-ter......
期刊： HEART AND VESSELS, 2022; 37 (1)
Growing evidences have revealed that a histone deacetylase inhibitor (HDACi), suberoylanilide hydroxamic acid (SAHA) has anti-fibrotic effect in diffe......
期刊： HEART AND VESSELS, 2022; 37 (2)
The association between fragmented QRS (fQRS) and autonomic nervous dysfunction, and major adverse cardiovascular events (MACE) is not fully clear in ......
期刊： HEART AND VESSELS, 2022; 37 (3)
Background Plasma ghrelin levels can be elevated in patients with acute heart failure (AHF). This study aimed to analyze the temporal changes and prog......
期刊： HEART AND VESSELS, 2022; 37 (5)
This study aimed to evaluate the variability of dabigatran plasma concentration and the association with clinical events in Chinese patients treated w......
期刊： HEART AND VESSELS, 2022; 37 (12)
Hemoptysis is a common clinical emergency, bronchial arterial embolization is considered to be an effective treatment. The presence of coronary artery......
期刊： HEART AND VESSELS, 2022; 37 (12)
The present study aimed to evaluate sex-specific association between admission systolic blood pressure (SBP) and in-hospital prognosis in patients wit......
期刊： HEART AND VESSELS, 2022; 37 (6)
Atherosclerosis (AS) is the basic lesion underlying the occurrence and development of cerebrovascular diseases. Abnormal proliferation of vascular smo......
期刊： HEART AND VESSELS, 2022; 37 (3)
There is scarce information about the risk factors for incomplete false lumen thrombosis (FLT) among type B aortic dissection (AD) patients, particula......
期刊： HEART AND VESSELS, 2022; 37 (12)
Catheter ablation is an effective method of rhythm therapy for atrial fibrillation (AF). AF recurrence is a common problem after catheter ablation. Th......
期刊： HEART AND VESSELS, 2022; 37 (7)
Systemic lupus erythematosus (SLE) is associated with an increased risk of cardiovascular disease. The purpose of the current study was to explore the......
期刊： HEART AND VESSELS, 2022; 37 (5)
To evaluate the efficacy and safety of tocilizumab (TCZ) in the treatment of refractory Takayasu arteritis (TAK). Eleven refractory TAK patients treat......
期刊： HEART AND VESSELS, 2022; 37 (7)
Hypertrophic cardiomyopathy (HCM) patients with nonvalvular atrial fibrillation (AF) have an increased risk of suffering thromboembolic events. Vitami......
期刊： HEART AND VESSELS, 2022; 37 (4)
Tpeak-Tend/QT ratio (Tp-e/QT) in patients with ST-segment elevation myocardial infarction (STEMI) is reportedly associated with major adverse cardiac ......
期刊： HEART AND VESSELS, 2022; 37 (3)
Background: Left ventricular thrombus (LVT) can complicate ST-Elevation myocardial infarction (STEMI) and is associated with poor outcomes. Convention......
